![](https://img.caixin.com/2021-03-23/1616495860712442.jpg)
China’s benchmark Shanghai Composite Index (000001.SH) lost 0.29% on Friday, while the Shenzhen Component Index (399001.SZ) fell 0.39%.
Shanghai’s tech-heavy STAR 50 Index (000688.SH) lost 0.12% for the day, while Shenzhen’s similar ChiNext Index (399006.SZ) rose 0.09%.
Below is a rundown of the top China business and finance stories, plus other news for the day:
· Guangzhou Pushes Life Toward Normalcy After Easing Covid Curbs
Southern China metropolis reopens shops and restaurants, resumes public transit and dismantles barriers around communities
· Commercial Banks Offer $310 Billion of Credit Lines to Developers
Cash-strapped real estate starts benefiting as authorities push for more borrowing capacity
· Opinion: China Needs Heartwarming Pandemic Policies in the Face of Winter’s Cold
Flexible, targeted, scientific disease control policies can help get China’s people humanely through the winter
· Sunac China Gets $1.15 Billion Cash Injection for Shanghai Project
State-owned Huarong and Citic take nearly 90% stake in Sunac unit that owns the incomplete Dongjiadu development
· Fosun Pharma Pours $220 Million Into France’s Cenexi
Acquisition of contract development and manufacturing organization and shareholder loan will expand the Chinese drugmaker’s footprint in Europe
· In Depth: U.S. Audit Row Dims Big Accounting’s Prospects in China
Caught in the crossfire of the dispute with Wall Street regulators and with growing competition at home, Chinese members of the global Big Four accounting networks face a tougher future in China
· Chinese Firms Talk Up Sodium Battery as Alternative for EVs
Companies including battery giant CATL are accelerating research and production of sodium-ion products as lithium prices soar
· China Targets Seniors in Renewed Covid Vaccination Drive
Authorities aim for 90% of people over 80 years old to have at least one dose by the end of next month, Caixin has learned
· China Says Dominant Omicron Strain Less of a Threat Than Original Covid
CDC comments may provide scientific justification for easing tough pandemic restrictions amid growing public frustration
· China’s Vice Premier Urges Refining Covid Response
Sun Chunlan says the country’s battle against the virus requires a new approach as the omicron variant becomes less pathogenic and vaccination rates increase
Click here to read more of the latest news.
This article was generated by Caixin Automation.
Follow the Chinese markets in real time with Caixin Global’s new stock database.